Reports

Sale

Neglected Tropical Disease Treatment Market

Global Neglected Tropical Disease Treatment Market Growth: By Type: Antiparasitic Drugs, Antibacterial Drugs, Antiviral Drugs; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, Key Indicators for Demand, Key Indicators for Price; Value Chain Analysis; Competitive Landscape; 2024-2032

Global Neglected Tropical Disease Treatment Market Outlook

The global neglected tropical disease treatment market is expected to grow at a CAGR of 6% over the forecast period of 2024-2032.

 

Global Neglected Tropical Disease Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

It is expected that the initiatives undertaken by several organisations worldwide to raise understanding and access to medicines for neglected tropical diseases will fuel the growth of the global neglected tropical disease treatment market. The growing prevalence of neglected tropical diseases has given rise to awareness-raising and the increased investment in the R&D sector to develop drugs for its treatment.

 

Market Segmentation

Neglected tropical diseases are a group of tropical infections, which are widespread in low-income communities, particularly in developing regions like Africa and Asia. These are caused by a variety of pathogens, including viruses, bacteria, protozoa, and helminths.

 

Global Neglected Tropical Disease Treatment Market By Type

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The global neglected tropical disease treatment industry can be divided based on segments like types and regions.

The industry can be broadly categorised based on its types into:

  • Antiparasitic Drugs
  • Antibacterial Drugs
  • Antiviral Drugs

The EMR report looks into the regional neglected tropical disease treatment markets like North America, Latin America, Europe, the Asia Pacific, and the Middle East and Africa.

 

Global Neglected Tropical Disease Treatment Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

Some of the root causes of neglected tropical diseases are the lack of proper hygiene, the lack of basic services such as clean water, and inadequate steps to prevent diseases. The governments across the nations are taking concerted measures to reduce the spread of neglected tropical diseases. India's Stop Dengue campaign aims to reduce dengue-related mortality and morbidity in the country by motivating people to adopt better health practices. In addition, organisations such as WHO are supporting the nation by providing free bed nets to reduce the number of malaria cases. These factors are expected to support the development of the global market for neglected tropical disease treatment in the future.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global neglected tropical disease treatment market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Bayer AG
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer Inc.
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Region
Breakup by Type
  • Antiparasitic Drugs
  • Antibacterial Drugs
  • Antiviral Drugs
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Bayer AG
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer Inc.
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Neglected Tropical Disease Treatment Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Neglected Tropical Disease Treatment Historical Market (2018-2023) 
    8.3    Global Neglected Tropical Disease Treatment Market Forecast (2024-2032)
    8.4    Global Neglected Tropical Disease Treatment Market by Type
        8.4.1    Antiparasitic Drugs
            8.4.1.1    Historical Trend (2018-2023)
            8.4.1.2    Forecast Trend (2024-2032)
        8.4.2    Antibacterial Drugs
            8.4.2.1    Historical Trend (2018-2023)
            8.4.2.2    Forecast Trend (2024-2032)
        8.4.3    Antiviral Drugs
            8.4.3.1    Historical Trend (2018-2023)
            8.4.3.2    Forecast Trend (2024-2032) 
    8.5    Global Neglected Tropical Disease Treatment Market by Region
        8.5.1    North America
            8.5.1.1    Historical Trend (2018-2023)
            8.5.1.2    Forecast Trend (2024-2032)
        8.5.2    Europe
            8.5.2.1    Historical Trend (2018-2023)
            8.5.2.2    Forecast Trend (2024-2032)
        8.5.3    Asia Pacific
            8.5.3.1    Historical Trend (2018-2023)
            8.5.3.2    Forecast Trend (2024-2032)
        8.5.4    Latin America
            8.5.4.1    Historical Trend (2018-2023)
            8.5.4.2    Forecast Trend (2024-2032)
        8.5.5    Middle East and Africa
            8.5.5.1    Historical Trend (2018-2023)
            8.5.5.2    Forecast Trend (2024-2032)
9    North America Neglected Tropical Disease Treatment Market Analysis
    9.1    United States of America
        9.1.1    Historical Trend (2018-2023)
        9.1.2    Forecast Trend (2024-2032)
    9.2    Canada
        9.2.1    Historical Trend (2018-2023)
        9.2.2    Forecast Trend (2024-2032)
10    Europe Neglected Tropical Disease Treatment Market Analysis
    10.1    United Kingdom
        10.1.1    Historical Trend (2018-2023)
        10.1.2    Forecast Trend (2024-2032)
    10.2    Germany
        10.2.1    Historical Trend (2018-2023)
        10.2.2    Forecast Trend (2024-2032)
    10.3    France
        10.3.1    Historical Trend (2018-2023)
        10.3.2    Forecast Trend (2024-2032)
    10.4    Italy
        10.4.1    Historical Trend (2018-2023)
        10.4.2    Forecast Trend (2024-2032)
    10.5    Others
11    Asia Pacific Neglected Tropical Disease Treatment Market Analysis
    11.1    China
        11.1.1    Historical Trend (2018-2023)
        11.1.2    Forecast Trend (2024-2032)
    11.2    Japan
        11.2.1    Historical Trend (2018-2023)
        11.2.2    Forecast Trend (2024-2032)
    11.3    India
        11.3.1    Historical Trend (2018-2023)
        11.3.2    Forecast Trend (2024-2032)
    11.4    ASEAN
        11.4.1    Historical Trend (2018-2023)
        11.4.2    Forecast Trend (2024-2032)
    11.5    Australia
        11.5.1    Historical Trend (2018-2023)
        11.5.2    Forecast Trend (2024-2032)
    11.6    Others
12    Latin America Neglected Tropical Disease Treatment Market Analysis
    12.1    Brazil
        12.1.1    Historical Trend (2018-2023)
        12.1.2    Forecast Trend (2024-2032)
    12.2    Argentina
        12.2.1    Historical Trend (2018-2023)
        12.2.2    Forecast Trend (2024-2032)
    12.3    Mexico
        12.3.1    Historical Trend (2018-2023)
        12.3.2    Forecast Trend (2024-2032)
    12.4    Others
13    Middle East and Africa Neglected Tropical Disease Treatment Market Analysis
    13.1    Saudi Arabia
        13.1.1    Historical Trend (2018-2023)
        13.1.2    Forecast Trend (2024-2032)
    13.2    United Arab Emirates
        13.2.1    Historical Trend (2018-2023)
        13.2.2    Forecast Trend (2024-2032)
    13.3    Nigeria
        13.3.1    Historical Trend (2018-2023)
        13.3.2    Forecast Trend (2024-2032)
    13.4    South Africa
        13.4.1    Historical Trend (2018-2023)
        13.4.2    Forecast Trend (2024-2032)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Value Chain Analysis
16    Competitive Landscape

    16.1    Market Structure
    16.2    Company Profiles
        16.2.1    Bayer AG
            16.2.1.1    Company Overview
            16.2.1.2    Product Portfolio
            16.2.1.3    Demographic Reach and Achievements
            16.2.1.4    Certifications
        16.2.2    F. Hoffmann-La Roche Ltd
            16.2.2.1    Company Overview
            16.2.2.2    Product Portfolio
            16.2.2.3    Demographic Reach and Achievements
            16.2.2.4    Certifications
        16.2.3    GlaxoSmithKline plc
            16.2.3.1    Company Overview
            16.2.3.2    Product Portfolio
            16.2.3.3    Demographic Reach and Achievements
            16.2.3.4    Certifications
        16.2.4    Novartis AG
            16.2.4.1    Company Overview
            16.2.4.2    Product Portfolio
            16.2.4.3    Demographic Reach and Achievements
            16.2.4.4    Certifications
        16.2.5    Pfizer Inc.
            16.2.5.1    Company Overview
            16.2.5.2    Product Portfolio
            16.2.5.3    Demographic Reach and Achievements
            16.2.5.4    Certifications
        16.2.6    Others
17    Key Trends and Developments in the Market


List of Key Figures and Tables

1.    Global Neglected Tropical Disease Treatment Market: Key Industry Highlights, 2018 and 2032
2.    Global Neglected Tropical Disease Treatment Historical Market: Breakup by Type (USD Billion), 2018-2023
3.    Global Neglected Tropical Disease Treatment Market Forecast: Breakup by Type (USD Billion), 2024-2032
4.    Global Neglected Tropical Disease Treatment Historical Market: Breakup by Region (USD Billion), 2018-2023
5.    Global Neglected Tropical Disease Treatment Market Forecast: Breakup by Region (USD Billion), 2024-2032
6.    North America Neglected Tropical Disease Treatment Historical Market: Breakup by Country (USD Billion), 2018-2023
7.    North America Neglected Tropical Disease Treatment Market Forecast: Breakup by Country (USD Billion), 2024-2032
8.    Europe Neglected Tropical Disease Treatment Historical Market: Breakup by Country (USD Billion), 2018-2023
9.    Europe Neglected Tropical Disease Treatment Market Forecast: Breakup by Country (USD Billion), 2024-2032
10.    Asia Pacific Neglected Tropical Disease Treatment Historical Market: Breakup by Country (USD Billion), 2018-2023
11.    Asia Pacific Neglected Tropical Disease Treatment Market Forecast: Breakup by Country (USD Billion), 2024-2032
12.    Latin America Neglected Tropical Disease Treatment Historical Market: Breakup by Country (USD Billion), 2018-2023
13.    Latin America Neglected Tropical Disease Treatment Market Forecast: Breakup by Country (USD Billion), 2024-2032
14.    Middle East and Africa Neglected Tropical Disease Treatment Historical Market: Breakup by Country (USD Billion), 2018-2023
15.    Middle East and Africa Neglected Tropical Disease Treatment Market Forecast: Breakup by Country (USD Billion), 2024-2032
16.    Global Neglected Tropical Disease Treatment Market Structure

Key Questions Answered in the Report

The market is projected to grow at a CAGR of 6% between 2023 and 2032.

The major drivers of the industry include government intervention for hygiene and monetary and non-monetary help from major international non-governmental organisations like the WHO.

The rising awareness-raising and the increased investment in the R&D sector is expected to be a key trend guiding the growth of the industry.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The types of neglected tropical disease treatment available are antiparasitic drugs, antibacterial drugs, and antiviral drugs.

The leading players in this market are Bayer AG, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Novartis AG, and Pfizer Inc., amongst others.

Analyst Review

The global neglected tropical disease treatment market was driven by government intervention for hygiene and monetary and non-monetary help from major international non-governmental organisations like the WHO. Aided by the rising awareness-raising and the increased investment in the R&D sector, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 6%.

EMR’s meticulous research methodology delves deep into the industry, covering the macro and micro aspects of the industry. The major regional markets for xx are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. Based on the type, the neglected tropical disease treatment market can be segmented into antiparasitic drugs, antibacterial drugs and antiviral drugs. The key players in the above industry include Bayer AG, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Novartis AG, and Pfizer Inc., amongst others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER